Nordea Investment Management Ab Has Boosted By $3.17 Million Its Adobe Systems (ADBE) Holding; Weiss Asset Management LP Has Increased Neurocrine Biosciences (NBIX) Stake By $335,566

April 21, 2018 - By Louis Casey

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Logo

Weiss Asset Management Lp increased Neurocrine Biosciences Inc (NBIX) stake by 124.27% reported in 2017Q4 SEC filing. Weiss Asset Management Lp acquired 4,358 shares as Neurocrine Biosciences Inc (NBIX)’s stock rose 13.16%. The Weiss Asset Management Lp holds 7,865 shares with $610,000 value, up from 3,507 last quarter. Neurocrine Biosciences Inc now has $7.14 billion valuation. The stock increased 1.56% or $1.22 during the last trading session, reaching $79.4. About 523,000 shares traded. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has risen 91.92% since April 21, 2017 and is uptrending. It has outperformed by 80.37% the S&P500.

Nordea Investment Management Ab increased Adobe Systems (ADBE) stake by 4.36% reported in 2017Q4 SEC filing. Nordea Investment Management Ab acquired 18,088 shares as Adobe Systems (ADBE)’s stock rose 22.17%. The Nordea Investment Management Ab holds 433,318 shares with $75.94M value, up from 415,230 last quarter. Adobe Systems now has $110.92B valuation. The stock decreased 1.05% or $2.38 during the last trading session, reaching $225.24. About 2.09M shares traded. Adobe Systems Incorporated (NASDAQ:ADBE) has risen 66.71% since April 21, 2017 and is uptrending. It has outperformed by 55.16% the S&P500.

Since October 23, 2017, it had 1 buy, and 15 sales for $83.49 million activity. The insider LAMKIN BRYAN sold $5.97M. $1.26M worth of Adobe Systems Incorporated (NASDAQ:ADBE) was sold by DILLON MICHAEL A on Wednesday, January 31. On Wednesday, December 13 the insider Lewnes Ann sold $338,846. 165,023 shares were sold by NARAYEN SHANTANU, worth $32.66 million. THOMPSON MATTHEW also sold $379,784 worth of Adobe Systems Incorporated (NASDAQ:ADBE) shares. $10.21M worth of Adobe Systems Incorporated (NASDAQ:ADBE) shares were sold by GARRETT MARK. 21,276 shares were sold by GESCHKE CHARLES M, worth $3.97M.

Nordea Investment Management Ab decreased Trex (NYSE:TREX) stake by 7,518 shares to 21,399 valued at $2.32 million in 2017Q4. It also reduced Factset Research Systems (NYSE:FDS) stake by 13,388 shares and now owns 27,713 shares. Bb&T (NYSE:BBT) was reduced too.

Investors sentiment decreased to 0.89 in 2017 Q4. Its down 0.22, from 1.11 in 2017Q3. It is negative, as 47 investors sold ADBE shares while 389 reduced holdings. 107 funds opened positions while 280 raised stakes. 410.42 million shares or 1.09% less from 414.95 million shares in 2017Q3 were reported. C M Bidwell & Ltd holds 0.56% of its portfolio in Adobe Systems Incorporated (NASDAQ:ADBE) for 3,675 shares. Ngam Advisors Lp reported 96,170 shares. Stephens Ar reported 45,726 shares. The Florida-based Suncoast Equity Management has invested 3.4% in Adobe Systems Incorporated (NASDAQ:ADBE). Strategy Asset Managers Limited, a New Jersey-based fund reported 44,419 shares. Lpl Financial Lc, California-based fund reported 93,910 shares. Moreover, Violich Capital has 0.13% invested in Adobe Systems Incorporated (NASDAQ:ADBE). Nichols And Pratt Advisers Llp Ma reported 0.11% stake. Tower Rech Ltd Liability Company (Trc) owns 10,744 shares for 0.24% of their portfolio. Dekabank Deutsche Girozentrale owns 0.2% invested in Adobe Systems Incorporated (NASDAQ:ADBE) for 167,083 shares. Thompson Davis And Company owns 0.05% invested in Adobe Systems Incorporated (NASDAQ:ADBE) for 125 shares. Outfitter Advsrs Ltd reported 40,092 shares stake. 913,360 are owned by Credit Suisse Ag. Cornerstone Cap Ltd holds 0.18% or 143,579 shares. Mason Street Advisors Ltd Liability has 0.28% invested in Adobe Systems Incorporated (NASDAQ:ADBE) for 68,663 shares.

Among 39 analysts covering Adobe Systems (NASDAQ:ADBE), 28 have Buy rating, 0 Sell and 11 Hold. Therefore 72% are positive. Adobe Systems had 157 analyst reports since August 11, 2015 according to SRatingsIntel. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, June 20 report. The rating was maintained by Morgan Stanley on Friday, March 16 with “Equal-Weight”. The company was initiated on Thursday, March 31 by Canaccord Genuity. The firm earned “Hold” rating on Monday, March 26 by JMP Securities. The firm has “Buy” rating given on Wednesday, September 21 by Citigroup. The rating was maintained by KeyBanc Capital Markets on Wednesday, October 18 with “Buy”. The firm earned “Neutral” rating on Friday, March 18 by Credit Suisse. On Friday, December 11 the stock rating was maintained by FBR Capital with “Mkt Perform”. The stock of Adobe Systems Incorporated (NASDAQ:ADBE) earned “Outperform” rating by Bernstein on Friday, March 18. The firm has “Buy” rating by Canaccord Genuity given on Thursday, December 14.

Since January 2, 2018, it had 0 insider buys, and 22 insider sales for $29.59 million activity. Shares for $6.83 million were sold by Bozigian Haig P.. The insider BENEVICH ERIC sold $68,174. OBrien Christopher Flint sold $138,499 worth of stock or 1,750 shares. 5,000 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shares with value of $415,380 were sold by LYONS GARY A. Another trade for 2,046 shares valued at $169,997 was sold by Grigoriadis Dimitri E.. RASTETTER WILLIAM H sold $855,000 worth of stock or 9,500 shares. $128,460 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was sold by Gano Kyle.

Among 13 analysts covering Neurocrine Biosci (NASDAQ:NBIX), 13 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Neurocrine Biosci had 54 analyst reports since August 18, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, October 20 by BMO Capital Markets. The firm has “Buy” rating given on Wednesday, November 1 by BMO Capital Markets. On Tuesday, October 10 the stock rating was maintained by Leerink Swann with “Buy”. Jefferies upgraded it to “Buy” rating and $69.0 target in Tuesday, October 3 report. The stock of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) earned “Buy” rating by Needham on Thursday, February 22. The company was maintained on Friday, August 4 by H.C. Wainwright. Oppenheimer maintained the stock with “Buy” rating in Tuesday, March 13 report. The rating was maintained by Oppenheimer with “Buy” on Tuesday, December 12. The firm earned “Buy” rating on Thursday, September 21 by Robert W. Baird. The firm has “Buy” rating by Oppenheimer given on Thursday, February 22.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>